drugset / Trial / NCT00964353
Clinical and Economic Implications of Genetic Testing for Warfarin Management
Phase 4
Completed
359 enrolled
University of Chicago
Agency for Healthcare Research and Quality (AHRQ) · collab
RandomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to explore how knowing genes that individuals inherit from their parents can make warfarin dosing more safe and effective. This study is being done to determine whether providing doctors with data on the genes their patients inherited and warfarin dosing recommendations based on those genes affects the costs and outcomes of care and after hospitalization for patients from different ethnic/racial backgrounds, and how physicians use this information in decision making.
Timeline
- Start
- 2009-08
- Primary completion
- 2012-08
- Completion
- 2014-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Warfarin | Small molecule | — | — |